Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753908 · ClinicalTrials.gov registry record · Early Phase 1
Broccoli Sprout Extract in Treating Patients With Breast Cancer
A Early Phase 1 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT01753908 is a Early Phase 1 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 30 participants.
The verdict
NCT01753908, a Early Phase 1 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This randomized pilot trial studies broccoli sprout extract in treating patients with breast cancer. Broccoli sprout extract contains ingredients that may prevent or slow the growth of certain cancers. Studying samples of tissue from patients receiving broccoli sprout extract may help determine if it can enter breast tumor cells and how it affects certain biomarkers.
Interventions
- OTHER Placebo
- OTHER Laboratory Biomarker Analysis
- OTHER Pharmacological Study
- DRUG Broccoli Sprout Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-05-21 |
| Est. Completion | 2018-08-23 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01753908
The ClinicalTrials.gov registry entry for NCT01753908 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01753908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01753908 about?
NCT01753908 is a clinical study titled "Broccoli Sprout Extract in Treating Patients With Breast Cancer". This randomized pilot trial studies broccoli sprout extract in treating patients with breast cancer. Broccoli sprout extract contains ingredients that may prevent or slow the growth of certain cancers. Studying samples of tissue from patients receiving broccoli sprout extract may help determine if i...
What is the current status of trial NCT01753908?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2013-05-21. Estimated completion is 2018-08-23.
What interventions are being tested in trial NCT01753908?
The interventions under investigation include: Placebo (OTHER), Laboratory Biomarker Analysis (OTHER), Pharmacological Study (OTHER), Broccoli Sprout Extract (DRUG).
Who is sponsoring clinical trial NCT01753908?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.